abstract |
The invention discloses an immunomodulator, in particular to a class of compounds that inhibit IL-17A and its use as an immunomodulator in the preparation of medicines. The invention discloses the use of a compound represented by formula I or a stereoisomer thereof in the preparation of drugs for inhibiting IL-17A, and provides a method for clinical screening and/or preparation of drugs for diseases related to IL-17A activity. a new option. |